Xenon Pharmaceuticals Inc. (XENE)

Xenon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,144	2,989	3,503	2,466	1,643	554
Market Cap Growth	-2.62%	-14.68%	42.03%	50.06%	196.62%	57.13%
Enterprise Value	2,527	2,195	2,875	1,721	1,397	364
Last Close Price	41.92	39.20	46.06	39.43	31.24	15.38
PS Ratio	419.04	-	-	261.41	89.14	17.22
PB Ratio	5.09	3.96	3.78	3.42	2.99	3.23
P/TBV Ratio	4.96	3.96	3.78	3.42	2.99	3.23
PEG Ratio	-	2.51	2.51	2.51	2.51	2.51
EV/Sales Ratio	336.89	-	-	182.44	75.77	11.31
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.02
Asset Turnover	0.01	-	-	0.01	0.05	0.19
Quick Ratio	14.79	17.66	23.43	26.12	38.72	12.10
Current Ratio	15.14	17.85	23.65	26.44	39.03	12.30
Return on Equity (ROE)	-37.65%	-27.85%	-22.12%	-19.72%	-21.87%	-21.90%
Return on Assets (ROA)	-25.52%	-19.80%	-15.57%	-12.17%	-12.97%	-11.61%
Return on Capital (ROIC)	-26.57%	-20.50%	-16.01%	-12.51%	-13.47%	-13.82%
Earnings Yield	-8.85%	-7.84%	-5.21%	-5.08%	-4.80%	-5.21%
FCF Yield	-7.37%	-6.17%	-4.47%	-4.21%	-4.35%	-9.16%
Buyback Yield / Dilution	-7.80%	-16.45%	-10.48%	-38.77%	-21.09%	-23.57%

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q